Per Wold-Olsen is a Norwegian businessperson who has been at the head of 8 different companies. Currently, he is Chairman for Oncopeptides AB and Chairman of GN Store Nord A, Chairman of GN Audio A, Chairman of GN Hearing An and Chairman for GN Netcom A (which are all subsidiaries of GN Store Nord A).
He is also on the board of Gilead Sciences, Inc. and Bio Malter and Chairman for MMV Medicines for Malaria Venture.
In the past he was Regional Director & Vice President at MSD Scandinavia AS, President-Intercontinental Division at Merck & Co., Inc. and Chief Executive Officer for MSD (Norge) AS (a subsidiary of Merck & Co., Inc.) and Chairman-Supervisory Board of H. Lundbeck A.
He received an MBA from the University of Wisconsin and an MBA from BI Norwegian Business School.